Report Detail

Service & Software Global Cyclic Peptide Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4587931
  • |
  • 21 May, 2024
  • |
  • Global
  • |
  • 144 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Service & Software

Cyclic peptide services refer to service organizations that provide customized synthesis, analysis and other related services of cyclic peptides. Cyclic peptides are an important class of bioactive molecules with broad application prospects, such as drug research and development, biotechnology research and other fields.
According to our (Global Info Research) latest study, the global Cyclic Peptide Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Cyclic Peptide Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Cyclic Peptide Service market size and forecasts, in consumption value ($ Million), 2019-2030
Global Cyclic Peptide Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Cyclic Peptide Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Cyclic Peptide Service market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cyclic Peptide Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cyclic Peptide Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript Biotech, Eurogentec, LifeTein, Biopharma PEG Scientific, AnaSpec, Scitide, JPT, CD ComputaBio, Creative Peptides, Macrocyclos, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cyclic Peptide Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Cyclic Peptide Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cyclic Peptide Custom Synthesis Service
Cyclic Peptide Structure Analysis Services
Cyclic Peptide Biological Activity Evaluation Services
Others
Market segment by Application
Biopharmaceutical
Scientific Research
Others
Market segment by players, this report covers
GenScript Biotech
Eurogentec
LifeTein
Biopharma PEG Scientific
AnaSpec
Scitide
JPT
CD ComputaBio
Creative Peptides
Macrocyclos
Peptide Insitute
Genepep
Innovagen
Bachem
InnoPep
Bio-Synthesis
Biomatrik
CPC Scientific
Chinese Peptide
Hangzhou All Peptide
WuXi Discovery Services
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cyclic Peptide Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cyclic Peptide Service, with revenue, gross margin, and global market share of Cyclic Peptide Service from 2019 to 2024.
Chapter 3, the Cyclic Peptide Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Cyclic Peptide Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cyclic Peptide Service.
Chapter 13, to describe Cyclic Peptide Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cyclic Peptide Service by Type
    • 1.3.1 Overview: Global Cyclic Peptide Service Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Cyclic Peptide Service Consumption Value Market Share by Type in 2023
    • 1.3.3 Cyclic Peptide Custom Synthesis Service
    • 1.3.4 Cyclic Peptide Structure Analysis Services
    • 1.3.5 Cyclic Peptide Biological Activity Evaluation Services
    • 1.3.6 Others
  • 1.4 Global Cyclic Peptide Service Market by Application
    • 1.4.1 Overview: Global Cyclic Peptide Service Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Biopharmaceutical
    • 1.4.3 Scientific Research
    • 1.4.4 Others
  • 1.5 Global Cyclic Peptide Service Market Size & Forecast
  • 1.6 Global Cyclic Peptide Service Market Size and Forecast by Region
    • 1.6.1 Global Cyclic Peptide Service Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Cyclic Peptide Service Market Size by Region, (2019-2030)
    • 1.6.3 North America Cyclic Peptide Service Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Cyclic Peptide Service Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Cyclic Peptide Service Market Size and Prospect (2019-2030)
    • 1.6.6 South America Cyclic Peptide Service Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Cyclic Peptide Service Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 GenScript Biotech
    • 2.1.1 GenScript Biotech Details
    • 2.1.2 GenScript Biotech Major Business
    • 2.1.3 GenScript Biotech Cyclic Peptide Service Product and Solutions
    • 2.1.4 GenScript Biotech Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 GenScript Biotech Recent Developments and Future Plans
  • 2.2 Eurogentec
    • 2.2.1 Eurogentec Details
    • 2.2.2 Eurogentec Major Business
    • 2.2.3 Eurogentec Cyclic Peptide Service Product and Solutions
    • 2.2.4 Eurogentec Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Eurogentec Recent Developments and Future Plans
  • 2.3 LifeTein
    • 2.3.1 LifeTein Details
    • 2.3.2 LifeTein Major Business
    • 2.3.3 LifeTein Cyclic Peptide Service Product and Solutions
    • 2.3.4 LifeTein Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 LifeTein Recent Developments and Future Plans
  • 2.4 Biopharma PEG Scientific
    • 2.4.1 Biopharma PEG Scientific Details
    • 2.4.2 Biopharma PEG Scientific Major Business
    • 2.4.3 Biopharma PEG Scientific Cyclic Peptide Service Product and Solutions
    • 2.4.4 Biopharma PEG Scientific Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Biopharma PEG Scientific Recent Developments and Future Plans
  • 2.5 AnaSpec
    • 2.5.1 AnaSpec Details
    • 2.5.2 AnaSpec Major Business
    • 2.5.3 AnaSpec Cyclic Peptide Service Product and Solutions
    • 2.5.4 AnaSpec Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 AnaSpec Recent Developments and Future Plans
  • 2.6 Scitide
    • 2.6.1 Scitide Details
    • 2.6.2 Scitide Major Business
    • 2.6.3 Scitide Cyclic Peptide Service Product and Solutions
    • 2.6.4 Scitide Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Scitide Recent Developments and Future Plans
  • 2.7 JPT
    • 2.7.1 JPT Details
    • 2.7.2 JPT Major Business
    • 2.7.3 JPT Cyclic Peptide Service Product and Solutions
    • 2.7.4 JPT Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 JPT Recent Developments and Future Plans
  • 2.8 CD ComputaBio
    • 2.8.1 CD ComputaBio Details
    • 2.8.2 CD ComputaBio Major Business
    • 2.8.3 CD ComputaBio Cyclic Peptide Service Product and Solutions
    • 2.8.4 CD ComputaBio Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 CD ComputaBio Recent Developments and Future Plans
  • 2.9 Creative Peptides
    • 2.9.1 Creative Peptides Details
    • 2.9.2 Creative Peptides Major Business
    • 2.9.3 Creative Peptides Cyclic Peptide Service Product and Solutions
    • 2.9.4 Creative Peptides Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Creative Peptides Recent Developments and Future Plans
  • 2.10 Macrocyclos
    • 2.10.1 Macrocyclos Details
    • 2.10.2 Macrocyclos Major Business
    • 2.10.3 Macrocyclos Cyclic Peptide Service Product and Solutions
    • 2.10.4 Macrocyclos Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Macrocyclos Recent Developments and Future Plans
  • 2.11 Peptide Insitute
    • 2.11.1 Peptide Insitute Details
    • 2.11.2 Peptide Insitute Major Business
    • 2.11.3 Peptide Insitute Cyclic Peptide Service Product and Solutions
    • 2.11.4 Peptide Insitute Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Peptide Insitute Recent Developments and Future Plans
  • 2.12 Genepep
    • 2.12.1 Genepep Details
    • 2.12.2 Genepep Major Business
    • 2.12.3 Genepep Cyclic Peptide Service Product and Solutions
    • 2.12.4 Genepep Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Genepep Recent Developments and Future Plans
  • 2.13 Innovagen
    • 2.13.1 Innovagen Details
    • 2.13.2 Innovagen Major Business
    • 2.13.3 Innovagen Cyclic Peptide Service Product and Solutions
    • 2.13.4 Innovagen Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Innovagen Recent Developments and Future Plans
  • 2.14 Bachem
    • 2.14.1 Bachem Details
    • 2.14.2 Bachem Major Business
    • 2.14.3 Bachem Cyclic Peptide Service Product and Solutions
    • 2.14.4 Bachem Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Bachem Recent Developments and Future Plans
  • 2.15 InnoPep
    • 2.15.1 InnoPep Details
    • 2.15.2 InnoPep Major Business
    • 2.15.3 InnoPep Cyclic Peptide Service Product and Solutions
    • 2.15.4 InnoPep Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 InnoPep Recent Developments and Future Plans
  • 2.16 Bio-Synthesis
    • 2.16.1 Bio-Synthesis Details
    • 2.16.2 Bio-Synthesis Major Business
    • 2.16.3 Bio-Synthesis Cyclic Peptide Service Product and Solutions
    • 2.16.4 Bio-Synthesis Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Bio-Synthesis Recent Developments and Future Plans
  • 2.17 Biomatrik
    • 2.17.1 Biomatrik Details
    • 2.17.2 Biomatrik Major Business
    • 2.17.3 Biomatrik Cyclic Peptide Service Product and Solutions
    • 2.17.4 Biomatrik Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Biomatrik Recent Developments and Future Plans
  • 2.18 CPC Scientific
    • 2.18.1 CPC Scientific Details
    • 2.18.2 CPC Scientific Major Business
    • 2.18.3 CPC Scientific Cyclic Peptide Service Product and Solutions
    • 2.18.4 CPC Scientific Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 CPC Scientific Recent Developments and Future Plans
  • 2.19 Chinese Peptide
    • 2.19.1 Chinese Peptide Details
    • 2.19.2 Chinese Peptide Major Business
    • 2.19.3 Chinese Peptide Cyclic Peptide Service Product and Solutions
    • 2.19.4 Chinese Peptide Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Chinese Peptide Recent Developments and Future Plans
  • 2.20 Hangzhou All Peptide
    • 2.20.1 Hangzhou All Peptide Details
    • 2.20.2 Hangzhou All Peptide Major Business
    • 2.20.3 Hangzhou All Peptide Cyclic Peptide Service Product and Solutions
    • 2.20.4 Hangzhou All Peptide Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 Hangzhou All Peptide Recent Developments and Future Plans
  • 2.21 WuXi Discovery Services
    • 2.21.1 WuXi Discovery Services Details
    • 2.21.2 WuXi Discovery Services Major Business
    • 2.21.3 WuXi Discovery Services Cyclic Peptide Service Product and Solutions
    • 2.21.4 WuXi Discovery Services Cyclic Peptide Service Revenue, Gross Margin and Market Share (2019-2024)
    • 2.21.5 WuXi Discovery Services Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cyclic Peptide Service Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Cyclic Peptide Service by Company Revenue
    • 3.2.2 Top 3 Cyclic Peptide Service Players Market Share in 2023
    • 3.2.3 Top 6 Cyclic Peptide Service Players Market Share in 2023
  • 3.3 Cyclic Peptide Service Market: Overall Company Footprint Analysis
    • 3.3.1 Cyclic Peptide Service Market: Region Footprint
    • 3.3.2 Cyclic Peptide Service Market: Company Product Type Footprint
    • 3.3.3 Cyclic Peptide Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cyclic Peptide Service Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Cyclic Peptide Service Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Cyclic Peptide Service Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Cyclic Peptide Service Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Cyclic Peptide Service Consumption Value by Type (2019-2030)
  • 6.2 North America Cyclic Peptide Service Market Size by Application (2019-2030)
  • 6.3 North America Cyclic Peptide Service Market Size by Country
    • 6.3.1 North America Cyclic Peptide Service Consumption Value by Country (2019-2030)
    • 6.3.2 United States Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Cyclic Peptide Service Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Cyclic Peptide Service Consumption Value by Type (2019-2030)
  • 7.2 Europe Cyclic Peptide Service Consumption Value by Application (2019-2030)
  • 7.3 Europe Cyclic Peptide Service Market Size by Country
    • 7.3.1 Europe Cyclic Peptide Service Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 7.3.3 France Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Cyclic Peptide Service Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cyclic Peptide Service Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Cyclic Peptide Service Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Cyclic Peptide Service Market Size by Region
    • 8.3.1 Asia-Pacific Cyclic Peptide Service Consumption Value by Region (2019-2030)
    • 8.3.2 China Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 8.3.5 India Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Cyclic Peptide Service Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Cyclic Peptide Service Consumption Value by Type (2019-2030)
  • 9.2 South America Cyclic Peptide Service Consumption Value by Application (2019-2030)
  • 9.3 South America Cyclic Peptide Service Market Size by Country
    • 9.3.1 South America Cyclic Peptide Service Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Cyclic Peptide Service Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cyclic Peptide Service Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Cyclic Peptide Service Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Cyclic Peptide Service Market Size by Country
    • 10.3.1 Middle East & Africa Cyclic Peptide Service Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Cyclic Peptide Service Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Cyclic Peptide Service Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Cyclic Peptide Service Market Drivers
  • 11.2 Cyclic Peptide Service Market Restraints
  • 11.3 Cyclic Peptide Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cyclic Peptide Service Industry Chain
  • 12.2 Cyclic Peptide Service Upstream Analysis
  • 12.3 Cyclic Peptide Service Midstream Analysis
  • 12.4 Cyclic Peptide Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cyclic Peptide Service. Industry analysis & Market Report on Cyclic Peptide Service is a syndicated market report, published as Global Cyclic Peptide Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Cyclic Peptide Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,208.56
    4,812.84
    6,417.12
    531,500.40
    797,250.60
    1,063,000.80
    292,737.60
    439,106.40
    585,475.20
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report